Clinical StudiesResults Just In!
First Ever Human Clinical Study for
NOTE: This the study excluded patients with clear organic causes and risk factors of ED including vascular disease, diabetes mellitus, hypertension etc. Please see full report for complete exclusion criteria.
Here are VigRX Plus results
62.82% Increase inability to maintain erection
58.97% Increase in ability to penetrate partner
22.49% Increase in frequency and quality of orgasms
71.43% Increase in sexual and intercourse satisfaction
47.00% Increase in sex drive and desire
61.00% Increase in overall sexual satisfaction
We knew VigRX Plus was extremely powerful but even we were shocked at the results of the first-ever human clinical study. But since we know everyone does not have time to read a 56-page clinical study that took us two years to complete, below we have included a “Study Summary” to highlight key points and findings of the test.
Here are VigRX Plus Results:
but we didn’t know it was that good!
75 males between the age of 25-50 years, selected based on specific criteria outlined in the study. The duration of the study was 84 days, with frequent visits, exams and questionnaires to track changes. Each subject was given the daily recommended dosage for the duration of the test.
The “International Index of Erectile Function”, initially created to measure the results of prescription medications were used to measure results of VigRX Plus. This was a randomized double-blind study, in which half the subjects were given VigRX Plus and the other half was given a placebo.
All increases and improvements were measured directly against results from the placebo group.
What is the “International Index of Erection Function” (IIEF)?
Summary of VigRX Plus Clinical Study Report
(Study Conducted By Research Organization: Vedic Lifesciences Pvt.)
The VigRX Plus clinical study was designed to evaluate the effectiveness and safety of VigRX Plus in erectile dysfunction and male sexual health.
The test parameters and methodology included:
Here are VigRX Plus results:
- 75 males between the age of 25-50 years, selected based on specific criteria outlined in the study.
- The duration of the study was 84 days, with frequent visits, exams and questionnaires to track changes.
- Each subject was given the daily recommended dosage for the duration of the test.
- The “International Index of Erectile Function”, initially created to measure the results of prescription medications was used to measure results of VigRX Plus.
- This was a randomized double blind study, in which half the subjects were given VigRX Plus and the other half was given a placebo.
Patient and partner satisfaction was measured using the internationally recognized Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire.
Prior to the start of the study, the protocols and amendments were submitted to and formally approved by the Independent Institutional Ethics Committee (IEC).
The 75 men who participated in the study were between the ages of 25 and 50, in monogamous, heterosexual relationships.
They agreed to take the recommended dose of VigRX Plus®, which is two tablets, twice per day with meals for 12 weeks.
Out of 108 applicants screened, 78 were recruited for participation in the trial, and 75 completed the trial.
No participants had major psychiatric disorders, a history of heart conditions, diabetes, spinal cord injuries, deformities of the penis, HIV/Aids, or sexually transmitted diseases. None were alcoholics, used medications known to cause sexual dysfunction, had liver or renal dysfunction, erection issues caused by low testosterone, or had female partners who were pregnant.
62.82% Increase in ability
The inability to maintain an erection is a serious problem, affecting men of all ages.After taking VigRX Plus for 84 days, subjects saw a 62.82%improvement in their ability to maintain and control their erection when compared to the group taking placebo as demonstrated in the below chart.
59.97% Increase
Another important finding in this study was that the treatment satisfaction of the patients was also corroborated by their partners. In other words not only were the patients extremely satisfied with the results achieved when taking VigRX Plus, their partners also reported the same level of satisfaction.
More specifically the female partners of the patients reported and 59.97% increase in penetration, dramatically increasing overall satisfaction. And while partner satisfaction of the
VigRX Plus group actually increased during the study, the placebo group actually decreased over the same period! The chart below clearly demonstrates this substantial increase.
22.49% Increase
Over the test period there was a 22.49% improvement in orgasmic function which simply means the patients taking VigRX reported achieving 22.49% more orgasms than patients taking placebo.And more orgasms definitely equates to greater overall sexual satisfaction.
47.00% Increase
This is a very important statistic, further demonstrating why VigRX Plus could be considered superior to prescription medication.You see, prescription medication primarily focuses on increasing erection quality but does not impact sexual desire. This means that patients taking prescription medication can achieve an erection but do not necessarily desire OR find the act of performing intercourse satisfying.Whereas VigRX Plus focuses on both improving erection quality and sexual desire which means overall sexual and intercourse satisfaction increased dramatically!
71.43% Increase in
The patients taking VigRX plus for 84 days reported a 71.43% improvement in sexual and intercourse satisfaction where the placebo group only reported 12%.This means patients taking VigRX Plus found greater satisfaction – almost 6 times higher than the placebo group – when performing intercourse!.
61.00% Increase
And finally when all of the results were in, after 84 days the patients taking VigRX Plus reported a 61.00% increase in their overall sexual satisfaction.To further validate the findings the placebo group actually reported a decrease in overall sexual satisfaction!
Important Fact: Remember this was a “Double Blind Study” which means both the doctors and the researchers recording the data had no idea whether they were receiving placebo or genuine VigRX Plus in order to completely eliminate ANY bias in the results.
Erection Quality Scores Compared Over 12 Weeks:
As you can see, over the 12 week trial period, VigRX Plus® produced measurable increases in erection quality scores when compared to the placebo.
Study Participants Answered The Question:
“Would You Continue Taking VigRX Plus® Or The Placebo, Yes or No?”
